Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001171843-18-005735
Filing Date
2018-08-03
Accepted
2018-08-03 16:10:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B2 f424b2_080318.htm 424B2 575589
2 GRAPHIC logo2.jpg GRAPHIC 73676
3 GRAPHIC logo.jpg GRAPHIC 2966
  Complete submission text file 0001171843-18-005735.txt   682323
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-221421 | Film No.: 18991927
SIC: 2836 Biological Products, (No Diagnostic Substances)